Dermofast Ointment
Dermofast Ointment 15 g is a high‑potency topical combination containing a steroid (clobetasol), antibiotic (gentamicin), antifungal (clotrimazole), and antifungal/antiseptic agents (tolnaftate and iodo‑chlorhydroxyquinoline). It is designed for inflamed, itchy, and often infected‑appearing skin lesions suspected to have both fungal and bacterial components.
Dermofast Ointment combines:
- Clobetasol propionate 0.05% w/w - a very potent topical corticosteroid that rapidly reduces inflammation, redness, and itching.
- Gentamicin sulphate 0.01% w/w – an aminoglycoside antibiotic that helps control superficial bacterial infection.
- Tolnaftate 1.0% w/w – an antifungal agent effective against dermatophytes (tinea fungi).
- Iodo‑chlorhydroxyquinoline 1.0% w/w – an antiseptic and broad‑spectrum antimicrobial with activity against bacteria and some fungi.
- Clotrimazole 0.1% w/w – an azole antifungal that inhibits fungal cell‑membrane synthesis.
This ointment is typically applied thinly to affected skin once or twice daily for a short duration, under medical supervision, to control inflammation, itching, and mixed‑infection‑type dermatoses.
- Strong anti‑inflammatory and anti‑itch effect from clobetasol for stubborn eczema, psoriasis‑like plaques, lichenified or thickened areas, and severe dermatitis.
- Broad‑spectrum antimicrobial cover due to gentamicin, which helps prevent or treat secondary bacterial infection in broken or weeping skin.
- Antifungal coverage from clotrimazole and tolnaftate for ringworm, tinea corporis/inguinalis, and candida‑associated rashes.
- Antiseptic/antiseborrhoeic effect from iodo‑chlorhydroxyquinoline, useful in seborrheic or exudative dermatoses and pityriasis‑type lesions.
Overall, Dermofast is positioned as a high‑potency, “rescue”‑type ointment for intensely inflamed, itchy, and likely infected or fungus‑associated skin conditions.
Because of the very potent steroid (clobetasol), side effects can be significant if misused:
- Local skin reactions: burning, irritation, dryness, redness, thinning of skin, easy bruising, striae, acne‑like eruptions, and increased hair growth at the application site.
- Skin‑infection–related risks: steroid‑overuse can mask or worsen underlying fungal or bacterial infection; improper use may lead to secondary infection or steroid‑dependent dermatitis.
- Systemic effects (with large‑area/long‑term use): adrenal suppression, hypertension, hyperglycemia, or osteoporosis‑like features, though these are rare with short‑term, limited‑area use.
Contraindications include use on viral infections (e.g., herpes, chickenpox), tuberculous or syphilitic skin lesions, rosacea, perioral dermatitis, and open ulcers, and in children unless strictly advised.
Dermofast Ointment is best targeting the dermatology and general medicine segment dealing with:
- Dermatologists – for stubborn, thickened eczema, lichen simplex, psoriasis like plaques, chronic tinea with severe inflammation, and mixed bacterial–fungal intertrigo or groin dermatoses.
- General Physicians / Internal Medicine – for generalized itching, severe seborrheic/eczematous rashes, or recurrent fungal infections in elderly or diabetic patients.
- Endocrinologists / Diabetologists – for stubborn fungal or intertriginous infection in diabetic patients, where scratching and secondary infection are common.
